Primary proximal tubular acidosis (PPTA) is an inherited disorder characterized by impaired reabsorption of bicarbonate in the proximal tubules of the kidney. The main clinical manifestation is metabolic acidosis, which occurs due to loss of bicarbonate ions and accumulation of acids in the body. This condition can lead to a variety of systemic consequences, including osteoporosis, growth retardation, myopathy, and nephrocalcinosis. PPTA usually manifests in childhood but may not be recognized until adulthood if its manifestations are mild or not so severe.
History of the disease and interesting historical facts
The history of primary proximal tubular acidosis dates back to the early 20th century, when cases of metabolic acidosis in children with recurrent diseases were first described. The earliest references to this syndrome date back to the works of such medical pioneers as Halen and Rosinger. In the 1950s, it was established that PCA is associated with congenital disorders of the proximal tubule of the kidney and is associated with genetically determined defects in bicarbonate transport. Over the past decades, various genetic abnormalities causing this condition have been identified, greatly expanding our understanding of the pathogenesis of the disease. Modern research continues to identify new genes and mechanisms responsible for the development of PCA.
Epidemiology (statistics of disease occurrence)
The epidemiology of primary tubular proximal acidosis shows that it is a rare disease, but its prevalence varies from region to region. According to a study conducted in Europe, the incidence of PCA ranges from 1 in 100,000 to 1 in 250,000 births. Estimates show that the highest number of cases are recorded in highly inbreeding populations, where the normal incidence may reach 1 in 10,000. The gender distribution of the disease may also fluctuate: traditionally, males are considered to have more severe forms of the disease. However, there is still debate about how sex hormones may influence the symptoms and course of the disease.
Genetic predisposition to this disease
There is a clear genetic predisposition to PCPA, as supported by multiple studies identifying mutations in various genes involved in renal proximal tubular function. The most commonly reported genes include SLC4A4, SLC9A3, and others involved in bicarbonate and sodium transport. Mutations in the SLC4A4 gene result in abnormalities in the Na+/HCO3- cotransporter, which is the primary cause of the condition. In addition, other rare mutations in genes involved in tubular function have been reported, suggesting a complex genetic basis for PCPA.
Risk factors for the development of this disease
The main risk factors for developing primary tubular proximal acidosis are mostly genetic. However, some external factors may worsen the course of the disease, including:
- A family history of PCA – cases of PCA in close relatives may indicate a high risk of developing the disease.
- Infections that affect the bone and joint system, which can worsen symptoms in susceptible individuals.
- Conditions associated with long-term use of certain medications that may have a nephrotoxic effect.
- Toxic environmental influences, including chemicals that negatively affect kidney function.
Diagnosis of this disease
Diagnosis of primary proximal tubular acidosis involves a multidisciplinary approach consisting of clinical and laboratory tests. Key symptoms to look out for include:
- Dyspnea associated with metabolic acidosis.
- Frequent otitis and respiratory infections.
- Stunted growth or underweight in children.
- Pain in bones and muscles.
Laboratory studies are presented:
- Determination of the serum bicarbonate level, which will be reduced.
- Measurement of creatinine and urea levels to assess kidney function.
- A urine test to assess the loss of certain substances such as glucose and phosphates.
Radiological examinations may include bone scans to detect osteoporosis or nephrolithiasis. In the differential diagnosis, it is important to exclude other causes of metabolic acidosis, such as diabetic ketoacidosis or renal failure.
Treatment
Treatment of primary proximal tubular acidosis requires a comprehensive approach aimed at correcting metabolic acidosis and preventing serious complications. General measures include:
- Maintaining adequate hydration.
- Correction of acid-base balance with the help of a therapeutic diet.
- Pharmacological treatment using sodium bicarbonate to increase serum bicarbonate levels.
Pharmacological treatment often includes:
- Baking soda (sodium bicarbonate) to manage acidosis.
- Conditions for the prevention of osteoporosis through the use of vitamin D and calcium.
- Medicines to manage symptoms if they become severe.
In rare cases, if medical treatment is not enough, surgery may be required, such as a nephrectomy if nephrocalcinosis or other complications develop.
List of medications used to treat this disease
The main drugs for the treatment of primary proximal tubular acidosis include:
- Sodium soda salt for acidosis correction.
- Calcium in combination with vitamin D to improve bone density.
- Drugs that inhibit acid secretion, such as proton pump inhibitors.
Disease monitoring
Monitoring the condition of patients with primary tubular proximal acidosis plays an important role in the long-term management of the disease and requires regular control steps, including:
- Periodic laboratory tests to assess bicarbonate levels.
- Monitoring renal function with serial creatinine measurements.
- Assessment of growth and development in children.
The prognosis for patients who receive adequate treatment is generally good. However, it is important to consider potential complications, such as osteoporosis and dental problems, that can develop as a result of chronic bicarbonate deficiency.
Age-related features of the disease
Primary tubular proximal acidosis may manifest itself at different ages, but symptoms are most often noticed in childhood. In children, the disease may be accompanied by growth retardation and the development of osteoporosis. In adult patients, PCPA often manifests itself in a less pronounced form, but its chronic course can lead to serious consequences associated with metabolic disorders. Elderly people, as a rule, have risks of concomitant diseases that can complicate the course of PCPA and lead to the need for constant monitoring of health status.
Questions and Answers
- What is primary tubular proximal acidosis?
It is an inherited disorder characterized by impaired reabsorption of bicarbonate in the kidneys, resulting in metabolic acidosis. - What are the main symptoms of PCPA?
The main symptoms include growth retardation, frequent infections, dyspnea and myopathy. - How is this disease diagnosed?
Diagnosis includes laboratory tests, urine analysis and, if necessary, radiological examination methods. - What is the prognosis for treating PCPA?
The prognosis with adequate treatment is usually good, but complications such as osteoporosis are possible. - What medications are used to treat PCPA?
The main drugs include sodium bicarbonate, calcium and vitamin D.
